| Financial Year |
March 31 2023 |
| Monetary Funds |
384,082,308.65 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,134,303.75 |
| Accounts Receivable |
27,663,064.72 |
| Advances to Suppliers |
4,778,248.04 |
| Other Receivables |
1,787,377.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
85,018,728.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
393,517.03 |
| Total Current Assets |
506,857,548.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,973,637.09 |
| Investment Properties |
13,427,436.07 |
| Fixed Assetes |
83,423,909.59 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,710,481.62 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,325,883.20 |
| Deferred Income Tax Assets |
2,242,258.09 |
| Other Non-Current Assets |
2,284,548.03 |
| Sub-Total of Non-Current Assets |
137,476,021.96 |
| Total Assets |
644,333,570.78 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
9,047,225.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,656,027.27 |
| Taxes Payable |
5,707,026.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,442,129.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,589,983.55 |
| Other Current Liabilities |
1,483,830.66 |
| Sub-Total of Current Liabilities |
46,120,619.25 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,510,222.37 |
| Total Liabilities |
52,630,841.62 |
| Paid-In Capital(Or Share Stock) |
194,877,256.00 |
| Capital Surplus |
71,836,899.03 |
| Surplus Reserve |
47,377,396.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
275,454,819.88 |
| Minority Stockholder's Interest |
2,103,612.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
589,599,116.96 |
| Owner's Equity（Stockholder's Equity） |
591,702,729.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
644,333,570.78 |
